Smith Hayes Advisers’s Celgene Corp CELG Stock Holding History

Smith Hayes Advisers’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$344K	Sell	3,437 -3,236	-48%	-$333K	0.07%	239
2015 Q4	$799K	Hold	6,673	–	–	0.17%	151
2015 Q3	$722K	Sell	6,673 -332	-5%	-$41.2K	0.16%	158
2015 Q2	$811K	Buy	7,005 +255	+4%	+$29.2K	0.16%	145
2015 Q1	$778K	Buy	6,750 +1,353	+25%	+$162K	0.15%	161
2014 Q4	$604K	Buy	5,397 +1,053	+24%	+$111K	0.13%	185
2014 Q3	$412K	Buy	4,344 +600	+16%	+$54.1K	0.1%	205
2014 Q2	$322K	Buy	3,744 +382	+11%	+$29.1K	0.08%	223
2014 Q1	$235K	Buy	3,362 +50	+2%	+$3.96K	0.06%	252
2013 Q4	$280K	Sell	3,312 -110	-3%	-$8.7K	0.09%	204
2013 Q3	$264K	Hold	3,422	–	–	0.1%	196
2013 Q2	$200K	Buy	+3,422	New	+$206K	0.08%	216

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Smith Hayes Advisers's CELG Position: Q1 2016 in Review

Smith Hayes Advisers reduced its Celgene Corp (CELG) stake by 48% in Q1 2016, selling an estimated $333K and leaving 3,437 shares worth $344K. The position accounts for 0.07% of the portfolio, ranked #239.

Smith Hayes Advisers first reported a position in CELG in Q2 2013 and has held it in 12 quarters since. The position peaked at $811K in Q2 2015. 1,224 funds tracked by Wall St. Rank hold CELG as of Q1 2016.

Smith Hayes Advisers held 3,437 shares of Celgene Corp worth $344K as of Q1 2016.
Smith Hayes Advisers sold 3,236 Celgene Corp shares in Q1 2016, an estimated $333K.
Celgene Corp made up 0.07% of Smith Hayes Advisers's portfolio in Q1 2016, its #239 holding.
Smith Hayes Advisers first reported a position in Celgene Corp in Q2 2013 and has held it in 12 quarters since.
Smith Hayes Advisers's Celgene Corp position peaked at $811K in Q2 2015.
1,224 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2016.

Based on Smith Hayes Advisers's 13F filing for Q1 2016, filed 16 May 2016.